TDB approves funding for MIM in MedTech
Technology Development Board supports commercialisation of Metal Injection Molding of implants
Technology Development Board supports commercialisation of Metal Injection Molding of implants
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
Nureca Ltd has reported financial results for the period ended June 30, 2021.
The company posted net profit of Rs.594.6 crores for the period ended June 30, 2020.
Our specialty chemical businesses have continued to perform strongly, growing double digit YoY
For patients with resectable early-stage gastric and gastroesophageal junction cancers
The company would be commissioning 3 hubs in Q2 FY26 across our Core Geography and West Bengal
The company reported consolidated EBITDA loss of Rs. 10.5 crore in Q1 FY26 as compared to loss of Rs. 45.3 crore in the same period last year
His experience includes leadership roles in manufacturing, strategic management, and commercial operations across the pharmaceuticals, healthcare, and specialty chemicals sectors
Subscribe To Our Newsletter & Stay Updated